Industrial Microbiology Market by Product Type (Consumables, Equipment & Systems, Laboratory Supplies), Test Type (Bio-Burden Testing, Microbial Limits Testing, Sterility Testing), Application - Global Forecast 2024-2030
Description
Industrial Microbiology Market by Product Type (Consumables, Equipment & Systems, Laboratory Supplies), Test Type (Bio-Burden Testing, Microbial Limits Testing, Sterility Testing), Application - Global Forecast 2024-2030
The Industrial Microbiology Market size was estimated at USD 17.06 billion in 2023 and expected to reach USD 18.41 billion in 2024, at a CAGR 8.11% to reach USD 29.46 billion by 2030.
Industrial microbiology involves the use of microorganisms for the production of industrial products in large quantities. It applies scientific and engineering principles to the processing of biological samples and materials by microorganisms to create useful products. An integral part of the bio-economy, industrial microbiology contributes to the development of new technologies and products that impact various sectors, including pharmaceuticals, food and beverages, and biofuels, among others. The demand for industrial microbiology is influenced by diverse factors, such as increasing government support for bio-based products and the growing necessity for renewable energy sources. The industry also encompasses the production of enzymes, antibiotics, and biopesticides and the process of fermentation to produce beer, wine, and cheese. However, the possibility of process contamination and the need for precise control of environmental parameters complicate industrial microbiology's production and manufacturing processes. Additionally, a lack of skilled research and technical personnel poses challenges to the optimum operation of machinery, equipment, and microbiological processes. However, manufacturers are investing efforts in imposing stringent quality control strategies and exploring the integration of advanced technologies such as AI, IoT, and robotics to reduce the chances of manual error. Furthermore, continual advancements in molecular biology, genomics, and proteomics have greatly enhanced the capabilities and applications of industrial microbiology.
Regional Insights
Industrial microbiology is well embedded in the pharmaceutical and agriculture sectors in the Americas. Major producers include the U.S. and Canada, where several multinational biotech companies are headquartered. This region has shown rapid growth due to the heavy investment in research and development. Authorities such as the Food and Drug Administration (FDA) and Health Canada are working on providing approvals for advanced industrial microbiology equipment and tests in the region. Asia holds a considerable market share in the industrial microbiology market, with the primary users being India and China, where sectors such as healthcare, food & beverages, and agriculture are major contributors. The region has seen advancements due to the increased use of biotechnological processes in manufacturing. The European region, including Germany, the UK, and France, makes substantial use of industrial microbiology, majorly in the pharmaceutical and food & beverage sectors. Investments in research & development and the presence of established biotech companies make Europe a strong player. Guidelines by the European Medicines Agency (EMA) and European Food Safety Authority (EFSA) enable the building of a safe and secure market for industrial microbiology that can cater to various industrial standards.
Market Insights
- Market Dynamics
The market dynamics represent an ever-changing landscape of the Industrial Microbiology Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.- Market Drivers
- Growing production of antibiotics, drug products, and natural cosmetic ingredients
- Rising concerns about waste management and government initiatives for renewable energy
- Increasing consumer preference for novel and nutritionally rich food and beverage options
- Market Restraints
- Chances of contamination and the need for precise control of environmental parameters
- Market Opportunities
- Advancements and research initiatives to optimize industrial microbiology processes
- Inclination towards adoption of precision agriculture for efficient crop production
- Market Challenges
- Limitations of machinery and process handling of industrial microbiology and lack of skilled personnel
- Market Segmentation Analysis
- Product: Development of advanced equipment for streamlining industrial microbiology processes
- Test Type: Utilization of microbial limits testing to ensure sterility of pharmaceutical and medical products
- Application: Growing sustainability and waste management concerns driving the utilization of industrial microbiology in the environmental industry
- Market Disruption Analysis
- Porter’s Five Forces Analysis
- Value Chain & Critical Path Analysis
- Pricing Analysis
- Technology Analysis
- Patent Analysis
- Trade Analysis
- Regulatory Framework Analysis
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Industrial Microbiology Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Industrial Microbiology Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments- QIAGEN Launches Complete Sample to Insight Workflow for Microbiome Research
QIAGEN introduced its Microbiome WGS SeqSets, a comprehensive suite empowering microbiome research through a streamlined workflow from sample preparation to in-depth bioinformatic analysis. This innovation combines high-performance DNA extraction kits, sophisticated library preparation optimized for whole genome metagenomics, and advanced yet accessible bioinformatics tools. The product offers applications in varied fields, such as gut microbiology, soil ecosystem studies, and the monitoring of antibiotic resistance.
New Acquisition to Accelerate Microbiome Therapeutics Manufacture
Kanvas Biosciences acquired assets from Federation Bio, enabling the company to expedite the production and clinical investigation of intricate microbial consortia. This acquisition has facilitated the establishment of two active microbiome-based clinical programs by Kanvas to enhance its business offering.
Eppendorf Introduces the First Microcentrifuge with Hydrocarbon Cooling
Eppendorf unveiled the innovative centrifuge 5427 R, the company's microcentrifuge featuring hydrocarbon cooling technology. As the latest advancement in molecular and cell biology applications, the Centrifuge 5427 R represents an advancement in sustainable laboratory operations by integrating a refrigeration system that utilizes R290, a natural refrigerant with a minimal Global Warming Potential (GWP).
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Industrial Microbiology Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Industrial Microbiology Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Agilent Technologies, Inc., Asiagel Corporation, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BioMerieux SA, bNovate Technologies SA, Bruker Corporation, Charles River Laboratories International, Inc., Condalab, Corning Incorporated, Cysal GmbH, Danaher Corporation, ELITechGroup Inc., Eppendorf SE, Fujifilm Holdings Corporation, HiMedia Laboratories Private Limited, HyLabs Ltd., Merck KGaA, Microbe Investigations AG, Novamed, Ltd. by Simplivia Healthcare Ltd., Qiagen N. V., Reshape ApS, Sartorius AG, Solenis LLC, Sporian Microsystems Inc., SSI Diagnostica A/S, Sysmex Corporation, Thermo Fisher Scientific Inc., and Vermicon AG.
Market Segmentation & Coverage
This research report categorizes the Industrial Microbiology Market to forecast the revenues and analyze trends in each of the following sub-markets:- Product Type
- Consumables
- Media
- Reagents & Strains
- Equipment & Systems
- Air Monitoring Systems
- Automated Equipment
- Filtration Pumps & Systems
- Incubators & Culture Apparatus
- Microbial Detection Systems
- Laboratory Supplies
- Bags & Bottles
- Filtration Disc & Membranes
- Loop & Needles
- Petri Dishes, Racks, Seals, Plates & Holders
- Test Type
- Bio-Burden Testing
- Microbial Limits Testing
- Sterility Testing
- Water & Environmental Testing
- Application
- Agricultural
- Cosmetic or Personal Care
- Environmental
- Food & Beverage
- Pharmaceutical & Biotechnology
- Wastewater & Sewage Treatment
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
- Americas
- Consumables
- Market Drivers
Table of Contents
186 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing production of antibiotics, drug products, and natural cosmetic ingredients
- 5.1.1.2. Rising concerns about waste management and government initiatives for renewable energy
- 5.1.1.3. Increasing consumer preference for novel and nutritionally rich food and beverage options
- 5.1.2. Restraints
- 5.1.2.1. Chances of contamination and the need for precise control of environmental parameters
- 5.1.3. Opportunities
- 5.1.3.1. Advancements and research initiatives to optimize industrial microbiology processes
- 5.1.3.2. Inclination towards adoption of precision agriculture for efficient crop production
- 5.1.4. Challenges
- 5.1.4.1. Limitations of machinery and process handling of industrial microbiology and lack of skilled personnel
- 5.2. Market Segmentation Analysis
- 5.2.1. Product: Development of advanced equipment for streamlining industrial microbiology processes
- 5.2.2. Test Type: Utilization of microbial limits testing to ensure sterility of pharmaceutical and medical products
- 5.2.3. Application: Growing sustainability and waste management concerns driving the utilization of industrial microbiology in the environmental industry
- 5.3. Market Trend Analysis
- 5.3.1. Technological advances in industrial microbiology solutions in the Americas region backed by strong presence of key players and increasing demand from developed industrial landscape
- 5.3.2. Potential for expansion and technology integration in the industrial microbiology sector of emerging countries in APAC, driven by the rise of sustainable practices, and availability of expertise
- 5.3.3. Strong R&D background of EMEA region in industrial microbiology backed by the presence of established companies and robust government initiatives to accelerate microbe usage across industries
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework Analysis
- 6. Industrial Microbiology Market, by Product Type
- 6.1. Introduction
- 6.2. Consumables
- 6.3. Equipment & Systems
- 6.4. Laboratory Supplies
- 7. Industrial Microbiology Market, by Test Type
- 7.1. Introduction
- 7.2. Bio-Burden Testing
- 7.3. Microbial Limits Testing
- 7.4. Sterility Testing
- 7.5. Water & Environmental Testing
- 8. Industrial Microbiology Market, by Application
- 8.1. Introduction
- 8.2. Agricultural
- 8.3. Cosmetic or Personal Care
- 8.4. Environmental
- 8.5. Food & Beverage
- 8.6. Pharmaceutical & Biotechnology
- 8.7. Wastewater & Sewage Treatment
- 9. Americas Industrial Microbiology Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Industrial Microbiology Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Industrial Microbiology Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. Market Share Analysis, 2023
- 12.2. FPNV Positioning Matrix, 2023
- 12.3. Competitive Scenario Analysis
- 12.3.1. QIAGEN Launches Complete Sample to Insight Workflow for Microbiome Research
- 12.3.2. New Acquisition to Accelerate Microbiome Therapeutics Manufacture
- 12.3.3. Eppendorf Introduces the First Microcentrifuge with Hydrocarbon Cooling
- 12.3.4. bNovate Technologies Raises USD 13.4 Million(~CHF 12 million)
- 12.3.5. Solvay Announces Plans to Build a Multipurpose Microbiology Lab in Europe
- 12.3.6. Charles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID
- 12.3.7. Visolis and Ginkgo Bioworks Announce Partnership to Improve Microbial Strain for Bio-Isoprene and Sustainable Aviation Fuel Production
- 12.3.8. Sysmex to Establish New Manufacturing Base in India – Creating a manufacturing structure in India to Support Sustainable Growth
- 12.3.9. Sartorius Stedim Biotech to Acquire Polyplus
- 12.3.10. InDevR Partners with bioMérieux
- 12.3.11. BD Launches Third-GenerationTotal Lab Automation System
- 12.3.12. 3M Invests USD 146M in Biopharma Filtration Technology
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.2. Key Product Portfolio
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
